Paper17599165
Update on the safety considerations in the management of insomnia with hypnotics: incorporating modified-release formulations into primary care.
Lieberman JA. Prim Care Companion J Clin Psychiatry, 2007. Cited by 32 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Update on the safety considerations in the management of insomnia with hypnotics: incorporating modified-release formulations into primary care. Papers, record 17599165. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17599165
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Update on the safety considerations in the management of insomnia with hypnotics: incorporating modified-release formulations into primary care.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8,143,886 | Pilot controlled double-blind study of the hypnotic effects of zolpidem in patients with chronic 'learned' insomnia: psychometric and polysomnographic evaluation. | J Int Med Res | 1993 | https://conductscience.org/library/papers/8143886 | PubMed |
| 2 | 15,649,738 | Melatonin as a hypnotic: pro. | Sleep Med Rev | 2005 | https://conductscience.org/library/papers/15649738 | PubMed |
| 3 | 7,984,354 | Recent developments in the behavioral pharmacology of benzodiazepine (omega) receptors: evidence for the functional significance of receptor subtypes. | Neurosci Biobehav Rev | 1994 | https://conductscience.org/library/papers/7984354 | PubMed |
| 4 | 16,815,744 | Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia. | Sleep Med | 2006 | https://conductscience.org/library/papers/16815744 | PubMed |
| 5 | 6,133,538 | The use of short- and long-acting hypnotics in clinical medicine. | Br J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/6133538 | PubMed |
| 6 | 11,465,523 | Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study. | J Clin Psychiatry | 2001 | https://conductscience.org/library/papers/11465523 | PubMed |
| 7 | 10,548,105 | Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. | Nature | 1999 | https://conductscience.org/library/papers/10548105 | PubMed |
| 8 | 7,525,193 | Guidelines for the rational use of benzodiazepines. When and what to use. | Drugs | 1994 | https://conductscience.org/library/papers/7525193 | PubMed |
| 9 | 430,730 | Rebound insomnia. A potential hazard following withdrawal of certain benzodiazepines. | JAMA | 1979 | https://conductscience.org/library/papers/430730 | PubMed |
| 10 | 7,140,142 | Quazepam and flurazepam: long-term use and extended withdrawal. | Clin Pharmacol Ther | 1982 | https://conductscience.org/library/papers/7140142 | PubMed |
| 11 | 15,226,287 | Treatment of primary insomnia. | J Am Board Fam Pract | 2004 | https://conductscience.org/library/papers/15226287 | PubMed |
| 12 | 2,391,399 | Diphenhydramine: pharmacokinetics and pharmacodynamics in elderly adults, young adults, and children. | J Clin Pharmacol | 1990 | https://conductscience.org/library/papers/2391399 | PubMed |
| 13 | 10,211,871 | Zaleplon pharmacokinetics and absolute bioavailability. | Biopharm Drug Dispos | 1999 | https://conductscience.org/library/papers/10211871 | PubMed |
| 14 | 10,682,226 | Lack of residual sedation following middle-of-the-night zaleplon administration in sleep maintenance insomnia. | Clin Neuropharmacol | 2000 | https://conductscience.org/library/papers/10682226 | PubMed |
| 15 | 16,444,900 | Memory effects of benzodiazepines: memory stages and types versus binding-site subtypes. | Neural Plast | 2005 | https://conductscience.org/library/papers/16444900 | PubMed |
| 16 | 8,071,269 | A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia. | J Clin Psychiatry | 1994 | https://conductscience.org/library/papers/8071269 | PubMed |
| 17 | 16,477,959 | A 2-week efficacy and safety study of eszopiclone in elderly patients with primary insomnia. | Sleep | 2005 | https://conductscience.org/library/papers/16477959 | PubMed |
| 18 | 12,531,146 | Epidemiology of insomnia: what we know and what we still need to learn. | Sleep Med Rev | 2002 | https://conductscience.org/library/papers/12531146 | PubMed |
| 19 | 10,582,735 | H1-receptor antagonists: safety issues. | Ann Allergy Asthma Immunol | 1999 | https://conductscience.org/library/papers/10582735 | PubMed |
| 20 | 15,680,290 | An assessment of the efficacy and safety of eszopiclone in the treatment of transient insomnia in healthy adults. | Sleep Med | 2005 | https://conductscience.org/library/papers/15680290 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39,115,347 | Effects of a Triage Checklist to optimize insomnia treatment outcomes and reduce hypnotic use: the RCT of the effectiveness of stepped-care sleep therapy in general practice study. | Sleep | 2025 | https://conductscience.org/library/papers/39115347 | PubMed |
| 38,321,804 | Is there a better way to wean chronic benzodiazepine receptor agonists use by substituting a DORA (and starting CBT-I)? | J Clin Sleep Med | 2024 | https://conductscience.org/library/papers/38321804 | PubMed |
| 38,288,131 | Developing, validating, and comparing an analytical method to simultaneously detect z-drugs in urine samples using the QuEChERS approach with both liquid chromatography and gas chromatography-tandem mass spectrometry. | Saudi Pharm J | 2024 | https://conductscience.org/library/papers/38288131 | PubMed |
| 38,131,058 | Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports. | Ment Health Clin | 2023 | https://conductscience.org/library/papers/38131058 | PubMed |
| 30,002,617 | The Orexin/Receptor System: Molecular Mechanism and Therapeutic Potential for Neurological Diseases. | Front Mol Neurosci | 2018 | https://conductscience.org/library/papers/30002617 | PubMed |
| 28,584,913 | Effects of different doses of triazolam in the middle-of-the-night insomnia: a double-blind, randomized, parallel group study. | J Neurol | 2017 | https://conductscience.org/library/papers/28584913 | PubMed |
| 25,984,284 | Persistent psychosis after abuse of high dose of zolpidem. | Addict Health | 2014 | https://conductscience.org/library/papers/25984284 | PubMed |
| 25,372,144 | Zolpidem reduces hippocampal neuronal activity in freely behaving mice: a large scale calcium imaging study with miniaturized fluorescence microscope. | PLoS One | 2014 | https://conductscience.org/library/papers/25372144 | PubMed |
| 23,620,678 | An approach to long-term sedative-hypnotic use. | Nat Sci Sleep | 2012 | https://conductscience.org/library/papers/23620678 | PubMed |
| 23,114,457 | Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and Z-drugs consumption in nine European countries. | Eur J Clin Pharmacol | 2013 | https://conductscience.org/library/papers/23114457 | PubMed |
| 22,560,522 | Relationship of zolpidem and cancer risk: a Taiwanese population-based cohort study. | Mayo Clin Proc | 2012 | https://conductscience.org/library/papers/22560522 | PubMed |
| 22,549,286 | Orexin receptor antagonism, a new sleep-enabling paradigm: a proof-of-concept clinical trial. | Clin Pharmacol Ther | 2012 | https://conductscience.org/library/papers/22549286 | PubMed |
| 21,494,350 | Adverse reactions to zolpidem: case reports and a review of the literature. | Prim Care Companion J Clin Psychiatry | 2010 | https://conductscience.org/library/papers/21494350 | PubMed |
| 19,169,658 | [Use of zolpidem and zopiclone on private prescriptions between 1993 and 2007]. | Nervenarzt | 2009 | https://conductscience.org/library/papers/19169658 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17599165
GET https://conductscience.org/api/papers/v1/17599165/references?page=2